Afatinib is a protein kinase inhibitor, it is used for the treatment of patients with distinct types of metastatic (EGFR mutation positive) non-small cell lung carcinoma, developed by Boehringer Ingelheim.
Inventory Status
Ready Stock
Please as a distributor to view package sizes and prices